OpenAI Broadens Access to GPT-Rosalind for Life Sciences Research
OpenAI has widened access to its GPT-Rosalind model, currently available to enterprise giants such as Amgen and Moderna. This development aims to accelerate biological and drug discovery research through broader deployment of advanced AI tools.
· 49d ago
